These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Safety Profile of Benznidazole in the Treatment of Chronic Chagas Disease: Experience of a Referral Centre and Systematic Literature Review with Meta-Analysis. Crespillo-Andújar C; Venanzi-Rullo E; López-Vélez R; Monge-Maillo B; Norman F; López-Polín A; Pérez-Molina JA Drug Saf; 2018 Nov; 41(11):1035-1048. PubMed ID: 30006773 [TBL] [Abstract][Full Text] [Related]
8. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies. Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678 [TBL] [Abstract][Full Text] [Related]
9. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S; J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946 [TBL] [Abstract][Full Text] [Related]
10. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588 [TBL] [Abstract][Full Text] [Related]
12. An evaluation of benznidazole as a Chagas disease therapeutic. Caldas IS; Santos EG; Novaes RD Expert Opin Pharmacother; 2019 Oct; 20(15):1797-1807. PubMed ID: 31456439 [No Abstract] [Full Text] [Related]
13. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280 [TBL] [Abstract][Full Text] [Related]
14. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034 [TBL] [Abstract][Full Text] [Related]
17. Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study. Jurado Medina L; Chassaing E; Ballering G; Gonzalez N; Marqué L; Liehl P; Pottel H; de Boer J; Chatelain E; Zrein M; Altcheh J Lancet Infect Dis; 2021 Aug; 21(8):1141-1150. PubMed ID: 33836157 [TBL] [Abstract][Full Text] [Related]
18. Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Fabbro DL; Streiger ML; Arias ED; Bizai ML; del Barco M; Amicone NA Rev Soc Bras Med Trop; 2007; 40(1):1-10. PubMed ID: 17486245 [TBL] [Abstract][Full Text] [Related]
19. An update on benznidazole for the treatment of patients with Chagas disease. Thakare R; Dasgupta A; Chopra S Drugs Today (Barc); 2018 Jan; 54(1):15-23. PubMed ID: 29569658 [TBL] [Abstract][Full Text] [Related]